Medtronic Receives FDA Clearance for Nellcor Pulse Oximetry System with Nell-EQ Processor

Medtronic has secured FDA clearance for its Nellcor Pulse Oximetry System. This system features the new Nell-EQ Intelligent Processor. This technology is designed to improve reliability. It aims to serve diverse patients and various conditions. The Nell-EQ processor represents a new technological advancement. Reliability across different patient profiles is a key focus. The clearance marks a significant regulatory milestone. This development supports improved patient monitoring capabilities.